<DOC>
	<DOC>NCT01274325</DOC>
	<brief_summary>The purpose of this study is to test hypothesis if Sereflo (ICS/LABA) could reduce airway inflammation in asthmatic patients in the same as Seretide.</brief_summary>
	<brief_title>Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>Age between 2080 years Patients with asthma diagnosed by according to the American Thoracic Society criteria A baseline FEV1 &gt; or = 50% predicted with a reversibility of FEV1 after therapy with inhaled salbuterol (2.5 mg) of FEV1 12% or with provocative concentration of a methacholine causing a 20% fall in FEV1 (PC20) of &lt; or = 8 mg/mL Prescribed use of inhaled corticosteroids (any brand) for at least 12 weeks prior to study entry The daily prescribed dose of inhaled corticosteroids during the last 4 weeks prior to study entry should have been constant and at least 250 μg/day of fluticasone at least 400 μg/day of budesonide at least 500 μg/day of any other beclomethasone Be able to provide written informed consent Any asthma exacerbation or respiratory tract infection affecting asthma within 4 weeks prior to the randomization visit Intake of oral, parenteral corticosteroids within 4 weeks and/or depot parenteral corticosteroid within 12 weeks prior to the randomization visits Current or previous smoker with a smoking history of &gt; or = 10 pack years Previous randomization of treatment in the present study Known or suspected hypersensitivity to study therapy Use of any βblocking agent, including eyedrops Pregnancy, breastfeeding or planned pregnancy during the study. Fertile women not using acceptable contraceptive pill measures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>asthma</keyword>
</DOC>